The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Injectable Drug Delivery Devices Market Research Report 2024

Global Injectable Drug Delivery Devices Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1431918

No of Pages : 98

Synopsis
Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.
The global Injectable Drug Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Devices.
Report Scope
The Injectable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dickinson and Company
Baxter International
Schott
Eli Lilly
Pfizer
Gerresheimer
Terumo
Antares Pharma
Novo Nordik
Sanofi
Unilife
Zogenix
Hospira
Presage Bioscience
MicroCHIPS
Pearl Therapeutics
Genentech
Bend Research
Segment by Type
Devices
Formulation
Segment by Application
Immune Disorder
Cancer
Diabetes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Injectable Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Injectable Drug Delivery Devices
1.2 Injectable Drug Delivery Devices Segment by Type
1.2.1 Global Injectable Drug Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Devices
1.2.3 Formulation
1.3 Injectable Drug Delivery Devices Segment by Application
1.3.1 Global Injectable Drug Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Immune Disorder
1.3.3 Cancer
1.3.4 Diabetes
1.3.5 Others
1.4 Global Injectable Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery Devices Revenue 2019-2030
1.4.2 Global Injectable Drug Delivery Devices Sales 2019-2030
1.4.3 Global Injectable Drug Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Drug Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Drug Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery Devices, Product Type & Application
2.7 Injectable Drug Delivery Devices Market Competitive Situation and Trends
2.7.1 Injectable Drug Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Devices Players Market Share by Revenue
2.7.3 Global Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Injectable Drug Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Drug Delivery Devices Global Injectable Drug Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Injectable Drug Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Injectable Drug Delivery Devices Sales by Region: 2025-2030
3.3 Global Injectable Drug Delivery Devices Global Injectable Drug Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Injectable Drug Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Injectable Drug Delivery Devices Revenue by Region: 2025-2030
3.4 North America Injectable Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Drug Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Injectable Drug Delivery Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Drug Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Injectable Drug Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Drug Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Drug Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Drug Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Injectable Drug Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Drug Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Drug Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injectable Drug Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Injectable Drug Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Injectable Drug Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Injectable Drug Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Injectable Drug Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Injectable Drug Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Injectable Drug Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Injectable Drug Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Drug Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Drug Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Injectable Drug Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Injectable Drug Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Injectable Drug Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Injectable Drug Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Injectable Drug Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Injectable Drug Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Injectable Drug Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Drug Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dickinson and Company
6.1.1 Dickinson and Company Corporation Information
6.1.2 Dickinson and Company Description and Business Overview
6.1.3 Dickinson and Company Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dickinson and Company Injectable Drug Delivery Devices Product Portfolio
6.1.5 Dickinson and Company Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter International Injectable Drug Delivery Devices Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Schott
6.3.1 Schott Corporation Information
6.3.2 Schott Description and Business Overview
6.3.3 Schott Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Schott Injectable Drug Delivery Devices Product Portfolio
6.3.5 Schott Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly Injectable Drug Delivery Devices Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Injectable Drug Delivery Devices Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Gerresheimer
6.6.1 Gerresheimer Corporation Information
6.6.2 Gerresheimer Description and Business Overview
6.6.3 Gerresheimer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gerresheimer Injectable Drug Delivery Devices Product Portfolio
6.6.5 Gerresheimer Recent Developments/Updates
6.7 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo Injectable Drug Delivery Devices Product Portfolio
6.7.5 Terumo Recent Developments/Updates
6.8 Antares Pharma
6.8.1 Antares Pharma Corporation Information
6.8.2 Antares Pharma Description and Business Overview
6.8.3 Antares Pharma Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Antares Pharma Injectable Drug Delivery Devices Product Portfolio
6.8.5 Antares Pharma Recent Developments/Updates
6.9 Novo Nordik
6.9.1 Novo Nordik Corporation Information
6.9.2 Novo Nordik Description and Business Overview
6.9.3 Novo Nordik Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novo Nordik Injectable Drug Delivery Devices Product Portfolio
6.9.5 Novo Nordik Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sanofi Injectable Drug Delivery Devices Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Unilife
6.11.1 Unilife Corporation Information
6.11.2 Unilife Injectable Drug Delivery Devices Description and Business Overview
6.11.3 Unilife Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Unilife Injectable Drug Delivery Devices Product Portfolio
6.11.5 Unilife Recent Developments/Updates
6.12 Zogenix
6.12.1 Zogenix Corporation Information
6.12.2 Zogenix Injectable Drug Delivery Devices Description and Business Overview
6.12.3 Zogenix Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zogenix Injectable Drug Delivery Devices Product Portfolio
6.12.5 Zogenix Recent Developments/Updates
6.13 Hospira
6.13.1 Hospira Corporation Information
6.13.2 Hospira Injectable Drug Delivery Devices Description and Business Overview
6.13.3 Hospira Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hospira Injectable Drug Delivery Devices Product Portfolio
6.13.5 Hospira Recent Developments/Updates
6.14 Presage Bioscience
6.14.1 Presage Bioscience Corporation Information
6.14.2 Presage Bioscience Injectable Drug Delivery Devices Description and Business Overview
6.14.3 Presage Bioscience Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Presage Bioscience Injectable Drug Delivery Devices Product Portfolio
6.14.5 Presage Bioscience Recent Developments/Updates
6.15 MicroCHIPS
6.15.1 MicroCHIPS Corporation Information
6.15.2 MicroCHIPS Injectable Drug Delivery Devices Description and Business Overview
6.15.3 MicroCHIPS Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.15.4 MicroCHIPS Injectable Drug Delivery Devices Product Portfolio
6.15.5 MicroCHIPS Recent Developments/Updates
6.16 Pearl Therapeutics
6.16.1 Pearl Therapeutics Corporation Information
6.16.2 Pearl Therapeutics Injectable Drug Delivery Devices Description and Business Overview
6.16.3 Pearl Therapeutics Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Pearl Therapeutics Injectable Drug Delivery Devices Product Portfolio
6.16.5 Pearl Therapeutics Recent Developments/Updates
6.17 Genentech
6.17.1 Genentech Corporation Information
6.17.2 Genentech Injectable Drug Delivery Devices Description and Business Overview
6.17.3 Genentech Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Genentech Injectable Drug Delivery Devices Product Portfolio
6.17.5 Genentech Recent Developments/Updates
6.18 Bend Research
6.18.1 Bend Research Corporation Information
6.18.2 Bend Research Injectable Drug Delivery Devices Description and Business Overview
6.18.3 Bend Research Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bend Research Injectable Drug Delivery Devices Product Portfolio
6.18.5 Bend Research Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery Devices Industry Chain Analysis
7.2 Injectable Drug Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery Devices Production Mode & Process
7.4 Injectable Drug Delivery Devices Sales and Marketing
7.4.1 Injectable Drug Delivery Devices Sales Channels
7.4.2 Injectable Drug Delivery Devices Distributors
7.5 Injectable Drug Delivery Devices Customers
8 Injectable Drug Delivery Devices Market Dynamics
8.1 Injectable Drug Delivery Devices Industry Trends
8.2 Injectable Drug Delivery Devices Market Drivers
8.3 Injectable Drug Delivery Devices Market Challenges
8.4 Injectable Drug Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’